| The Pharmaceutical Journal |
|
News summary |
|
Related websites |
Scrap contract regulations, says OFT
Regulations that have stabilised the pharmacy market since 1987 should be scrapped, the Director General of Fair Trading, John Vickers, has recommended. After over a year of deliberations, the Office of Fair Trading says in a report published last week that deregulating the pharmacy market will give consumers more choice, benefits from greater competition and better access to services. It adds that the annual regulatory cost saving to businesses would be £16m with a saving to the Government of £10m. Consumers would benefit by a £30m drop in the cost of over-the-counter medicines. The value of the United Kingdom pharmacy market is £8.6bn. In addition, the OFT says that the regulations restrict consumer choice over pharmacy location and opening hours, reduce incentives for pharmacies to compete on customer services and hold back innovation and responsiveness to changing and growing consumer needs. Although the contract control regulations only constrain the award of NHS contracts to pharmacies that are neither necessary nor desirable for the proper provision of NHS pharmacy services, the OFT takes the view that they have effectively blocked new pharmacy businesses from the market.
Mr Vickers said: "The question is whether the regulations that control entry into the industry are unduly impeding the way that the market works to the ultimate detriment of the general public. Our answer to that question is yes. We believe that the regulations have impeded the working of the market in a detrimental way and that they should be lifted. They inhibit price competition, they stifle efficiency improvements and innovation, they limit the availability of pharmacy services and they impose substantial regulatory burdens." The Department of Health has committed itself to responding to the OFT recommendation by 17 April. Parliamentary Under-Secretary of State for Health for England David Lammy said: "This long-awaited report is a significant milestone for community pharmacy. But its recommendations have potentially far-reaching implications not just for pharmacists, but for doctors who dispense, the NHS and for patients as well." Representatives of pharmacy, GPs, the NHS and patients are to be invited to discuss the report with the DoH and the Department of Trade and Industry. News feature, p108 |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site Map | Contact us